Literature DB >> 10987662

Review of colorectal cancer and its metastases in rodent models: comparative aspects with those in humans.

M Kobaek-Larsen1, I Thorup, A Diederichsen, C Fenger, M R Hoitinga.   

Abstract

BACKGROUND AND
PURPOSE: Colorectal cancer (CRC) remains one of the most common cancer forms developing in industrialized countries, and its incidence appears to be rising. Studies of human population groups provide insufficient information about carcinogenesis, pathogenesis, and treatment of CRC. To study these phenomena in detail, a number of animal models of human CRC have been developed. The hypothetical ideal animal model should mimic the human disease in terms of morphology, biochemical alterations, and biological behavior. No existing model replicates the disease as an entity, but available models approximate many of the characteristics of human colonic carcinogenesis and metastasis. So far few comparative evaluations of the various animal models of CRC have been made.
CONCLUSION: Animal studies cannot replace human clinical trials, but they can be used as a pre-screening tool, so that human trials become more directed, with greater chances of success. The orthotopic transplantation of colon cancer cells into the cecum of syngeneic animals or intraportal inoculation appears to resemble the human metastatic disease most closely, providing a model for study of the treatment of metastases. Which model(s) to choose depends on the goal(s) of the experiment(s). The review published here can provide help in selecting the most optimal CRC model(s) for a certain purpose and in preventing unnecessary duplication of animal experimentation.

Entities:  

Mesh:

Year:  2000        PMID: 10987662

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  24 in total

Review 1.  Colorectal cancer models for novel drug discovery.

Authors:  Daniel Golovko; Dmitriy Kedrin; Ömer H Yilmaz; Jatin Roper
Journal:  Expert Opin Drug Discov       Date:  2015-08-21       Impact factor: 6.098

2.  Orthotopic transplantation model of human gastrointestinal cancer and detection of micrometastases.

Authors:  J H Cui; U Krueger; D Henne-Bruns; B Kremer; H Kalthoff
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

3.  Assessment of histone tail modifications and transcriptional profiling during colon cancer progression reveals a global decrease in H3K4me3 activity.

Authors:  Karen Triff; Mathew W McLean; Kranti Konganti; Jiahui Pang; Evelyn Callaway; Beiyan Zhou; Ivan Ivanov; Robert S Chapkin
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-16       Impact factor: 5.187

4.  Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia.

Authors:  Lillian Maggio-Price; Helle Bielefeldt-Ohmann; Piper Treuting; Brian M Iritani; Weiping Zeng; Andrea Nicks; Mark Tsang; Donna Shows; Phil Morrissey; Joanne L Viney
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

5.  Patient-Derived Orthotopic Xenograft models in gastric cancer: a systematic review.

Authors:  Rossella Reddavid; Simona Corso; Daniel Moya-Rull; Silvia Giordano; Maurizio Degiuli
Journal:  Updates Surg       Date:  2020-04-06

6.  In vivo measurement of the shape of the tissue-refractive-index correlation function and its application to detection of colorectal field carcinogenesis.

Authors:  Andrew J Gomes; Sarah Ruderman; Mart DelaCruz; Ramesh K Wali; Hemant K Roy; Vadim Backman
Journal:  J Biomed Opt       Date:  2012-04       Impact factor: 3.170

Review 7.  Novel translational strategies in colorectal cancer research.

Authors:  Ignacio Gil-Bazo
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

Review 8.  Roles for inflammation and regulatory T cells in colon cancer.

Authors:  Susan E Erdman; Theofilos Poutahidis
Journal:  Toxicol Pathol       Date:  2009-12-17       Impact factor: 1.902

9.  Antineoplastic potency of arylchloroethylurea derivatives in murine colon carcinoma.

Authors:  Elisabeth Miot-Noirault; Jean Legault; Florent Cachin; Emmanuelle Mounetou; Françoise Degoul; René C Gaudreault; Nicole Moins; Jean Claude Madelmont
Journal:  Invest New Drugs       Date:  2004-11       Impact factor: 3.850

10.  Orthotopic mouse model of colorectal cancer.

Authors:  William Tseng; Xianne Leong; Edgar Engleman
Journal:  J Vis Exp       Date:  2007-12-04       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.